First Analysis Upgrades Cambrex Corporation (CBM) to Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. PTC
2. PCVX
3. NVDA
4. SPY
5. META
6. MSFT
7. RXO
8. GOOGL
9. GMAB
10. BBIO

Go back to First Analysis Upgrades Cambrex Corporation (CBM) to Overweight

Cambrex Reports Third Quarter 2016 Financial Results

November 4, 2016 7:00 AM EDT

- Sales increased 8% in the quarter, full year sales and profit guidance increased -

- Acquisition of North Carolina based PharmaCore completed -

- Conference call at 8:30 a.m. ET on November 4, 2016 -

EAST RUTHERFORD, N.J., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), reports results for the third quarter ended September 30, 2016.

Highlights

Sales increased... More